244 related articles for article (PubMed ID: 21672577)
1. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3β.
Martin L; Page G; Terro F
Neurochem Int; 2011 Aug; 59(2):235-50. PubMed ID: 21672577
[TBL] [Abstract][Full Text] [Related]
2. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
4. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
5. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.
Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C
Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789
[TBL] [Abstract][Full Text] [Related]
6. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
7. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
8. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
[TBL] [Abstract][Full Text] [Related]
9. Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.
López-Menéndez C; Gamir-Morralla A; Jurado-Arjona J; Higuero AM; Campanero MR; Ferrer I; Hernández F; Ávila J; Díaz-Guerra M; Iglesias T
Hum Mol Genet; 2013 Feb; 22(3):466-82. PubMed ID: 23118350
[TBL] [Abstract][Full Text] [Related]
10. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
[TBL] [Abstract][Full Text] [Related]
12. Activation of the 5'-AMP-Activated Protein Kinase in the Cerebral Cortex of Young Senescence-Accelerated P8 Mice and Association with GSK3β- and PP2A-Dependent Inhibition of p-tau₃₉₆ Expression.
Kim HS; Moon S; Paik JH; Shin DW; Kim LS; Park CS; Ha J; Kang JH
J Alzheimers Dis; 2015; 46(1):249-59. PubMed ID: 25737046
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of tau aggregation by cdk5 and GSK3β.
Lee S; Hall GF; Shea TB
J Alzheimers Dis; 2011; 26(2):355-64. PubMed ID: 21677377
[TBL] [Abstract][Full Text] [Related]
14. Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis.
Rametti A; Esclaire F; Yardin C; Terro F
J Biol Chem; 2004 Dec; 279(52):54518-28. PubMed ID: 15475565
[TBL] [Abstract][Full Text] [Related]
15. Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes.
Goldbaum O; Richter-Landsberg C
Glia; 2002 Dec; 40(3):271-82. PubMed ID: 12420308
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
[TBL] [Abstract][Full Text] [Related]
17. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to GSK3β-induced tau phosphorylation differs between the young and aged hippocampus after Wnt signaling inhibition.
Salcedo-Tello P; Hernández-Ortega K; Arias C
J Alzheimers Dis; 2014; 39(4):775-85. PubMed ID: 24270208
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.
Cho DH; Lee EJ; Kwon KJ; Shin CY; Song KH; Park JH; Jo I; Han SH
J Neurochem; 2013 Sep; 126(5):685-95. PubMed ID: 23581463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]